Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Preliminary crystallographic analysis of neuraminidase N2 from a new influenza A virus.

Acta crystallographica. Section F, Structural biology and crystallization communications - 1 Aug 2013

Gao Feng, Bao Jinku

Abstract excerpt

Influenza virus is a major viral respiratory pathogen that causes yearly epidemics in temperate climates. The H3N2 subtype is one of the major causative agents of severe epidemics and plays a critical role in vaccine development. The neuraminidase (NA) inhibitors oseltamivir and zanamivir are two commercially available NA-targeted competitive antiviral drugs. However, their effectiveness has been compromised by...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Crystallography, X-Ray
Share to Gene Expression Regulation, Viral

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Influenza A Virus, H3N2 Subtype

Share to Mutation

Share to Neuraminidase

Source

Open in PubMed Open full text

Identifiers

PMID: 23908028
DOI: 10.1107/S1744309113013122
PMCID: PMC3729159

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Preliminary crystallographic analysis of neuraminidase N2 from a new influenza A virus.PMID 23908028Read ↗

The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design.Semantic proximity Read ↗

Optimization of N-Substituted Oseltamivir Derivatives as Potent Inhibitors of Group-1 and -2 Influenza A Neuraminidases, Including a Drug-Resistant Variant.Semantic proximity Read ↗

Identification of neuraminidase inhibitors against dual H274Y/I222R mutant strains.Semantic proximity Read ↗

Influenza neuraminidase: A druggable target for natural productsSemantic proximity Read ↗

The current strategies of optimization of oseltamivir against mutant neuraminidases of influenza A：A review.Semantic proximity Read ↗

Peramivir binding affinity with influenza A neuraminidase and research on its mutations using an induced-fit docking approach.Semantic proximity Read ↗

Expression, crystallization and preliminary X-ray diffraction analysis of the N-terminal domain of nsp2 from avian infectious bronchitis virus.Semantic proximity Read ↗

Structural Studies of Inhibitors with Clinically Relevant Influenza Endonuclease VariantsSemantic proximity Read ↗

Structural insight into the mechanism of neuraminidase inhibitor-resistant mutations in human-infecting H10N8 Influenza A virusSemantic proximity Read ↗

Novel Neuraminidase Inhibitors: Identification, Biological Evaluation and Investigations of the Binding ModeSemantic proximity Read ↗

A single E105K mutation far from the active site of influenza B virus neuraminidase contributes to reduced susceptibility to multiple neuraminidase-inhibitor drugs.Semantic proximity Read ↗

Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.